
|Slideshows|May 29, 2019
Migraine Matters
Author(s)Leo Robert
To kick off Migraine and Headache Awareness Month, the latest findings reported here may influence your approaches to diagnosis, treatment, and prevention and help you keep your patients informed.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
FDA Clears Investigational New Drug Application for Remyelinating Agent PTD802 in Multiple Sclerosis
2
Insights on Vibrance-2 Study Results of Alixorexton in Narcolepsy Type 2: Richard K. Bogan, MD, FCCP, FAASM
3
Tolebrutinib Approved in EU for Nonrelapsing Secondary Progressive MS, Marking First Disability-Targeting Therapy in the Indication
4
FDA and EMA Accepts Regulatory Applications for Cemdisiran in Generalized Myasthenia Gravis
5


















